Menu
1. Journée Mondiale de l’Ostéoporose 2020: Nouvelles recommandations, nouveau traitement
2. En 2020, plus de 500’000 personnes en Suisse souffrent d’Ostéoporose, causant plus de 80’000 fractures
3. Who to treat (ASCO guidelines 2015)
4. Calculation Tool (FRAX)
5. Recommandations 2015
6. How to treat ? (ASCO guidelines 2015)
7. New recommendations (2020)
8. Moderate and Low Risk
9. High Risk
10. Highest Risk
11. Imminent Risk of a second MOF after a first MOF
12. Imminent Risk of a second fracture after a first MOF
13. ASCO : Nouvelles recommandations pour le traitement de l'ostéoporose (2020) : définition du très haut risque
14. ASCO: Nouvelles recommandations pour le traitement de l’ostéoporose (2020) - Définition du très haut risque
15. Highest risk: Treatment
16. EFFECTS OF 24 MONTHS TREATMENT OF TERIPARATIDE COMPARED WITH RISEDRONATE ON NEW FRACTURES IN POSTMENOPAUSAL WOMEN
17. EFFECTS OF 24 MONTHS TREATMENT OF TERIPARATIDE COMPARED WITH RISEDRONATE ON NEW FRACTURES IN POSTMENOPAUSAL WOMEN
18. Bone forming drugs
19. STRUCTURE: Lumbar Spine BMD by DXA
20. Study - Romosumab treatment in postmenopausal women with osteoporosis
21. FRAME
22. Study - Romosumab or Alendronate for fracture prevention in women with osteoporosis
22.1. Demographic and clinical charactérstics of the patients at baseline
22.2. Incidence of new vertebral fracture through month 24
22.3. ARCH
22.4. Adverse events
23. FDA presnetation january 2019
24. New recommendations (2020)
Journée mondiale de l'ostéoporose 2020, Prof S. Ferrari, 20.10.20
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
SUBMIT ALL